Sign In
Buy GWPH
$218.96
+0 (+0%)
At Close: May 27, 2022
Will There Be More M&A for the Cannabis Industry in 2021?
06:55am, Friday, 12'th Feb 2021
The sector is hot again on the heels of two large deals.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
11:41am, Wednesday, 10'th Feb 2021
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
Cannabinoid Capital (Podcast)
09:00am, Wednesday, 10'th Feb 2021
Cannabinoid Capital (Podcast)
1 of the Most Surprising Biotech Acquisitions in Years
06:14am, Tuesday, 09'th Feb 2021
Few investors saw this one coming.
Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal
02:54pm, Sunday, 07'th Feb 2021
A blockbuster deal announced earlier this week could be a sign of a bright future for cannabidiol-oriented pharmaceutical companies. On Wednesday, cancer therapy developer Jazz Pharmaceuticals PLC (NA
Willow Biosciences is set to benefit from Jazz Pharmaceuticals acquisition of GW Pharmaceuticals
02:54pm, Sunday, 07'th Feb 2021
Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) recently-announced deal to acquire cannabis-derived drug maker GW Pharmaceuticals plc (NASDAQ:GWPH) for US$7.2 billion in cash and stock has boosted investor
Cannabis Stocks Fly High On Biden Administration Potential
12:26pm, Friday, 05'th Feb 2021
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will d
Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense
11:45am, Friday, 05'th Feb 2021
Jazz made a bold bet with the acquisition of GW Pharmaceuticals.
3 Marijuana Stocks With High Hopes for the Future
09:33am, Friday, 05'th Feb 2021
Marijuana stocks are soaring higher on a string of Democratic electoral wins. But not every company in this troubled sector is a winner.
Cannabis ETFs Spike on Jazz-GW Pharma Deal
11:20am, Thursday, 04'th Feb 2021
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - GWPH, VIE, FLIR, SNCA
06:51am, Thursday, 04'th Feb 2021
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: GW Pharmaceuticals plc (NASDAQ: GWPH) concerning pote
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GW Pharmaceuticals plc Buyout
05:33pm, Wednesday, 03'rd Feb 2021
WILMINGTON, Del., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating GW Pharmaceuticals plc (“GW Pharmaceuticals”) (NASDAQ GM: GWPH) regarding possible breach
Cannabis Stocks Pop on News of Jazz-GW Merger
04:55pm, Wednesday, 03'rd Feb 2021
Jazz Pharmaceuticals has agreed to acquire GW Pharmaceuticals, maker of the first epilepsy drug derived from marijuana, for $7.2 billion in cash and stock.
SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc
04:46pm, Wednesday, 03'rd Feb 2021
NEW YORK, Feb. 3, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GW Pharmaceuticals plc ("GWPH" or the
Jazz Pharmaceuticals to Acquire Cannabis Drug Company
02:23pm, Wednesday, 03'rd Feb 2021
The deal to buy GW Pharmaceuticals creates a leader in neuroscience.
